IDH2 and central nervous system cancer: Consequently, mutant IDH1and IDH2 activity cause aberrant DNA and histone methylation, which lead to widespread hypermethylation of cytosine–phosphate–guanine (CpG) islands a phenomenon termed the glioma CpG-island methylator phenotype (G-CIMP) (Malta et al., 2018).